138 related articles for article (PubMed ID: 37355209)
1. Evaluation of tumour size and rete testis invasion in progression free survival of our patients with stage i testicular seminoma. A retrospective observational study of a reference hospital center and literature review.
Yáñez-Castillo YM; Melgarejo-Segura MT; Gutiérrez-Tejero F; Arrabal-Martín M
Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):654-660. PubMed ID: 37355209
[TBL] [Abstract][Full Text] [Related]
2. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
[TBL] [Abstract][Full Text] [Related]
3. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
4. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
5. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
Aparicio J; Maroto P; García Del Muro X; Sánchez-Muñoz A; Gumà J; Margelí M; Sáenz A; Sagastibelza N; Castellano D; Arranz JA; Hervás D; Bastús R; Fernández-Aramburo A; Sastre J; Terrasa J; López-Brea M; Dorca J; Almenar D; Carles J; Hernández A; Germà JR
Ann Oncol; 2014 Nov; 25(11):2173-2178. PubMed ID: 25210015
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.
Aparicio J
Clin Transl Oncol; 2018 Oct; 20(10):1358-1359. PubMed ID: 29744734
[No Abstract] [Full Text] [Related]
9. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
11. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
[TBL] [Abstract][Full Text] [Related]
12. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
13. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
15. Stage I testicular seminoma risk-adapted therapeutic management.
Mrinakova B; Kajo K; Lehotska V; Ondrusova M; Balogova S; Pinakova Z; Novotna V; Usakova V; Fedorkova L; Waczulikova I; Kausitz J; Ondrus D
Neoplasma; 2021 May; 68(3):613-620. PubMed ID: 33502887
[TBL] [Abstract][Full Text] [Related]
16. Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
Chung PW; Gospodarowicz MK; Panzarella T; Jewett MA; Sturgeon JF; Tew-George B; Bayley AJ; Catton CN; Milosevic MF; Moore M; Warde PR
Eur Urol; 2004 Jun; 45(6):754-59; discussion 759-60. PubMed ID: 15149748
[TBL] [Abstract][Full Text] [Related]
17. Testicular seminoma: Are clinical features and treatment outcomes any different in India?
Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV
Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
[TBL] [Abstract][Full Text] [Related]
19. Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events.
Chandran EA; Chindewere A; North R; Jameson MB
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1310. PubMed ID: 33103860
[TBL] [Abstract][Full Text] [Related]
20. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]